Top specialty therapy drugs in the U.S. by percent of total spending 2016
This statistic shows the leading specialty therapeutic drugs in the United States in 2016, based on percent share of total specialty spending. Humira Pen (adalimumab) for inflammatory conditions had the highest percent of total specialty spending, reaching a share of 11.3 percent in that year.
